French pharma giant Sanofi's Indian arm is putting its 150,000 sq ft Mumbai headquarters on the block, as it shifts operations to a new leased office in Vikhroli.
Sanofi IndiaMumbaiOffice SpacePharmaceutical IndustryCommercial Real EstateReal Estate MumbaiJul 10, 2024
Sanofi India is selling its Mumbai headquarters to shift operations to a new leased office in Vikhroli and to monetize its asset.
The Powai asset is expected to fetch around Rs 250 crore based on current property rates.
Sanofi Consumer Healthcare Ltd is a separate legal entity demerged from Sanofi India to operate its consumer health business independently.
India is an important market for Sanofi due to its large talent pool and growing demand for pharmaceutical products.
The Indian office market is witnessing sustained growth in demand despite global sluggishness, with a surge in gross leasing to 33.5 million sq ft in the first half of the year.
Century Real Estate aims to achieve sales of Rs 21.00 billion
PNB Housing Finance shares have fallen 18% from their 52-week high. Is it a good time to buy?
Goa's villages are under threat from real estate agents, builders, and companies driven by greed, leading to environmental degradation and suffering for native residents.
India’s primary housing market is expected to witness a moderate single-digit price rise in 2025, following a significant 21% surge in 2024. Industry experts attribute this trend to strong demand and limited supply, with a growing focus on sustainability
The luxury real estate market in NCR is witnessing a rapid expansion, driven by increased sales and a surge in demand from high-net-worth individuals.
The U.S. State Department has announced that all waivers providing economic relief to Iran are under review, signaling a significant shift in policy and potential implications for international trade and relations.